Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sosondowah ankyrin repeat domain family member C (SOWAHC) is a human protein containing ankyrin repeat domains, a structural motif that facilitates protein–protein interactions and is present in proteins regulating transcription, cell cycle, and cytoskeletal organization. SOWAHC has been identified as a methylation-driven gene in lung squamous cell carcinoma, with hypomethylation and high expression correlating with poor prognosis, suggesting its involvement in regulating transcriptional networks and gene expression relevant to cancer progression. The protein belongs to the ankyrin repeat family but is not classified as a canonical receptor, enzyme, or transporter; its primary function appears to be nuclear regulation rather than cell surface signaling. Predicted protein interactors suggest possible involvement in cytoskeletal processes, but direct functional characterizations are limited. No drugs directly target SOWAHC, and there is no reported involvement in adverse effects or contraindications.
Not applicable. No clinically approved drugs or mechanisms of drug action have been described for SOWAHC.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sosondowah ankyrin repeat domain family member C (SOWAHC).